🔎 Trials Near Me

Početna › KOPB › Texas › Houston

Kliničke studije za KOPB u gradu Houston, TX

15 studija za KOPB traži sudionike na lokacijama u gradu Houston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

U tijeku regrutacijaFaza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

U tijeku regrutacijaFaza 3
  • Se Houston- Site Number : 8400120, Houston
  • Aavon Clinical Trials, Llc- Site Number : 8400166, Houston
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

U tijeku regrutacijaFaza 2
  • Baylor College of Medicine Medical Center, Houston
Od 40 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

U tijeku regrutacijaFaza 3
  • Trio Clinical Trials- Site Number : 8400106, Houston
  • HDH Research- Site Number : 8400104, Houston
  • Baylor College of Medicine- Site Number : 8400076, Houston
  • i još 2
Od 40 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

U tijeku regrutacijaFaza 2
  • Research Site, Houston
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

U tijeku regrutacijaFaza 2
  • Baylor College of Medicine, Houston
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

U tijeku regrutacijaFaza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

U tijeku regrutacijaFaza 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 mi udaljenosti
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

U tijeku regrutacijaFaza 2/3
  • Greater Heights & Memorial Pulmonary and Sleep, Houston
  • Houston Pulmonary Sleep and Allergy Associates, Houston
Od 35 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT07363694

STRIVE Post-Market Registry Study

U tijeku regrutacijaOpažajna studija
  • University of Texas Health Science Center at Houston, Houston
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

U tijeku regrutacijaFaza 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Od 40 do 75 godina · Oba spola · Ažurirano 28. srp 2026. · NCT07177339

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

U tijeku regrutacija
  • Houston Methodist/Primary Critical Care, Houston
Od 40 do 84 godina · Oba spola · Ažurirano 24. tra 2026. · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

U tijeku regrutacijaFaza 3
  • GSK Investigational Site, Houston
Od 40 do 80 godina · Oba spola · Ažurirano 9. tra 2026. · NCT06961214

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

U tijeku regrutacijaOpažajna studija
  • Horizon Clinical Research Group, Houston
Od 50 godina i više · Oba spola · Ažurirano 5. kol 2025. · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

U tijeku regrutacija
  • Respire Research Institute, Houston
Od 30 godina i više · Oba spola · Ažurirano 6. velj 2025. · NCT05204888

Studije za KOPB u drugim gradovima

Ostale studije u gradu Houston

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.